Signal Transduction and Targeted Therapy

Academic journal
  • Biomedicine
  • Pharmacology
LanguageEnglishEdited by
  • Carlo M. Croce
  • Kang Zhang
  • Yu-Quan Wei
Publication detailsHistory2016–presentPublisher
Nature Research
FrequencyContinuous
Open access
Yes
Impact factor
39.3 (2022)Standard abbreviations
ISO 4 (alt) · Bluebook (alt1 · alt2)
NLM (alt) · MathSciNet (alt Paid subscription required)ISO 4Signal Transduct. Target. Ther.Indexing
CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt)
MIAR · NLM (alt) · ScopusISSN2095-9907 (print)
2059-3635 (web)
LCCN2016243461OCLC no.1026877558Links
  • Journal homepage
  • Online archive

Signal Transduction and Targeted Therapy is a multidisciplinary peer-reviewed open access scientific journal covering biomedical research with a particular focus on signal transduction and its application to the drug development process. It was established in 2016 and is published by Nature Research. The editors-in-chief are Carlo M. Croce (Ohio State University), Kang Zhang (Macau University of Science and Technology), and Yu-Quan Wei (West China Medical Center). According to the Journal Citation Reports, the journal has a 2022 impact factor of 39.3.[1]

References

  1. ^ "Signal Transduction and Targeted Therapy". 2020 Journal Citation Reports. Web of Science (Science ed.). Clarivate Analytics. 2021.


  • v
  • t
  • e